For international orders (non-US), use this site. For US orders only, visit archerdx.com

Archer® FusionPlex® Sarcoma Kit

A targeted sequencing assay to simultaneously detect and identify fusions of 26 genes associated with soft tissue cancers. Read More...
Select Product(s)

Archer FusionPlex Sarcoma Kit - 8 reactions

AB0003

Price
 
 
Accessory Products

Archer MBC Adapters A17-A24

SA0042

Price
 
 

Archer MBC Adapters A25-A32

SA0043

Price
 
 

Archer MBC Adapters A33-A40

SA0044

Price
 
 

Archer MBC Adapters A41-A48

SA0045

Price
 
 

Archer SureShot ALK, RET, ROS1 Fusion Controls

AK0035-4

Price
 
 

Archer SureShot Negative Fusion Controls

AK0036-4

Price
 
 

Product Highlights

The Archer FusionPlex Sarcoma Kit is a targeted sequencing assay to simultaneously detect and identify fusions of 26 genes associated with soft tissue cancers. Using Archer’s proprietary Anchored Multiplex PCR-based enrichment (AMPTM), fusions of all genes in this kit can be identified in a single sequencing assay, even without prior knowledge of fusion partners or breakpoints.

  • Comprehensive - identify sarcoma-related fusions in a single assay
  • Detailed - characterize fusion partners at single-nucleotide resolution
  • Innovative - first comprehensive NGS-based sarcoma fusion test on the market
  • Streamlined - reduce turn-around time and reduce reflex testing

Specifications

Product Literature

Report on FFPE Extraction Methods

White Paper | PDF 2 MB

PreSeq RNA QC Assay

White Paper | PDF < 1 MB

Archer FusionPlex Assay Targets

Brochure | PDF 1 MB

Archer FusionPlex NGS Assays

Brochure | PDF 2 MB

Archer FusionPlex Sarcoma Panel

Brochure | PDF 2 MB

Manuals and Support Information

All Archer FusionPlex Support 

Related Products

Image Source
MiSeq Reagent Kits v2

MiSeq sequencing reagents in pre-filled, ready-to-use cartridges. Micro and nano formats are available for low output applications.


Image Source
MiniSeq Reagent Kit

MiniSeq Reagent Kits bring the power of Illumina NGS to labs of all sizes. Access cost-efficient sequencing, even for low numbers of samples.


Image Source
NextSeq 500/550 v2 Kits

These sequencing reagent kits offer a simplified workflow and improved data quality compared to the prior v1 kit version.


References
  1. Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin. Sarcoma Res. Oct 4;2(1), 14 (2012).
  2. Seattle Cancer Care Alliance, Sarcoma Website http://www.seattlecca.org/diseases/types-subtypes-sarcoma.cfm.
  3. Demicco EG, Maki RG, Lev DC, Lazar AJ. New therapeutic targets in soft tissue sarcoma. Adv. Anat. Pathol. May 19(3), 170-80 (2012).
  4. Ducimetiere F, Lurkin A, Ranchere-Vince D, et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One (2011).
  5. Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases. Cancer Dec 15 98(12) (2003).